title: Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.
abstract: Intrahepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.
authors.affiliation: Department of Oncology, Fondazione S. Maugeri, Istituto Scientifico di Pavia, Italy. guido.poggi@fsm.it
authors.forename: Guido
authors.initials: G
authors.lastname: Poggi
authors.forename: Pietro
authors.initials: P
authors.lastname: Quaretti
authors.forename: Claudio
authors.initials: C
authors.lastname: Minoia
authors.forename: Ilaria
authors.initials: I
authors.lastname: Palumbo
authors.forename: Laura
authors.initials: L
authors.lastname: Villani
authors.forename: Alessio
authors.initials: A
authors.lastname: Amatu
authors.forename: Cristina
authors.initials: C
authors.lastname: Teragni
authors.forename: Mario
authors.initials: M
authors.lastname: Scelsi
authors.forename: Federico
authors.initials: F
authors.lastname: Zappoli
authors.forename: Giovanni
authors.initials: G
authors.lastname: Bernardo
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001650:Bile Duct Neoplasms / Q000098:blood supply / Q000628:therapy*; D001653:Bile Ducts, Intrahepatic / Q000098:blood supply / Q000473:pathology*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D018281:Cholangiocarcinoma / Q000098:blood supply / Q000628:therapy*; D005260:Female; D006801:Humans; D008863:Microspheres; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D000077150:Oxaliplatin
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin